PharmaLectures.com

Courses › Pharma industry foundations › Nitrosamines: the impurity that cleared half a shelf, and how to stay off the recall list

Nitrosamines: the impurity that cleared half a shelf, and how to stay off the recall list

Your team answers the nitrosamine question before the inspector asks it.

  • 6 audio modulesthree lengths each
  • 1 h to 5 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • QC, RA, API staffwho it is written for

Why this training matters

An inspector asks for the nitrosamine risk assessment on a product that has sold for years. The file shows the active ingredient route but says nothing on the solvent, the amine or the packaging. Your team spends days rebuilding the case while the batch waits.

What changes after this course

Your quality control, regulatory affairs and active pharmaceutical ingredient staff trace the source, assess it against the European Medicines Agency questions and answers, and defend the file in the room. You hold one certificate per learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your active pharmaceutical ingredient team reads a supplier route and spots the step where nitrite meets an amine, before the route is fixed. The recovered solvent and the printed blister lidding with nitrocellulose get checked at the start, not after a customer complaint. Route changes are decided in the project meeting, not in a recall.

Regulatory affairs staff work through the European Medicines Agency questions and answers on the Article 5(3) referral under Regulation (EC) No 726/2004, product by product, with its three steps. The assessment file states what was checked, what the supplier said, and why a test is or is not needed. Nobody rewrites it the night before an inspection.

Quality control analysts choose between gas chromatography and liquid chromatography with mass spectrometry for each product, and validate the method under International Council for Harmonisation guideline Q2(R2). They show a quantification limit that sits under the acceptable intake derived with International Council for Harmonisation guideline M7. The report stands up when a reviewer questions it.

When a result lands above the limit, your team knows who is told, in what form, and how the variation to the marketing authorisation is built. In the inspection room, they answer from the file, say plainly what is still open, and agree a plan. The inspector leaves with notes, not a finding.

Who needs this training

  • Quality Control Analyst

    An inspector asks how your method reached its quantification limit. You open the validation report and show each parameter against guideline Q2(R2) and the acceptable intake, instead of promising to find it later.

  • Regulatory Affairs Manager

    A customer or authority asks for the status of every product under the nitrosamine questions and answers. You answer from a file that records each step, and the variation is ready when confirmatory testing ends.

  • Active Pharmaceutical Ingredient Development Scientist

    A new route uses a secondary amine and a nitrite quench. You raise the flag at the design review, while changing the step costs a meeting and not a revalidation.

  • Quality Assurance Manager

    You sign off the risk assessments and face the inspector. You see the supplier statements, the test results and the control strategy in one file, and you know which gaps to close before the visit.

Roles: Regulatory affairs, Quality control and laboratory, Production and engineering

Businesses: API and intermediates maker

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: any jurisdiction

Courses are in English. Other languages on request.

After this course your people can

  1. Trace the formation pathway of a nitrosamine in one of your own synthesis routes, from reagent to finished product.
  2. Write a product risk assessment that follows the three steps of the European Medicines Agency questions and answers.
  3. Work out an acceptable intake for a nitrosamine under International Council for Harmonisation guideline M7 and set a control limit under it.
  4. Check a nitrosamine method against the validation parameters of guideline Q2(R2) and spot the gap before the inspector does.
  5. Draft a variation to the marketing authorisation that lists the data a reviewer expects for a nitrosamine change.
  6. Decide when a result above the limit must be reported to the competent authority, and who in your company makes the call.
  7. Answer an inspector's opening questions on nitrosamine risk by pointing to the right page in your file.

What the company gets

  • A product with no nitrosamine file stops being a worry, because each assessment is written, dated and ready to hand over.
  • Variations to the marketing authorisation go out complete, so reviewers spend their time on your data and not on writing back for missing pieces.
  • Inspectors get a straight answer from the person who owns the topic, not a promise to call back.
  • Every learner finishes each module with a recorded multiple-choice questionnaire, and you hold a certificate per learner and a training record for each person.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 6 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 30 min25 min a module, for regulatory, quality and business-development staff
Expanded5 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Regulatory affairsStandard2 h 30 min
Quality control and laboratoryStandard2 h 30 min
Production and engineeringStandard2 h 30 min

Course outline: 6 modules

6 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Trace where nitrosamines form before the synthesis route is fixed

    • Why a nitrite in one reagent and an amine in another becomes a nitrosamine in your reactor.
    • How to read a supplier route and flag the quenching step where nitrite meets an amine.
    • Where nitrocellulose in printed blister lidding can pass a nitrosamine to the tablet.
  2. 2Write a risk assessment that meets European Medicines Agency guidelines

    • The three steps in the questions and answers document that set the order of your product reviews.
    • What to put in the file when an active ingredient supplier will not share its full route.
    • When a paper assessment is enough and when confirmatory testing has to follow.
  3. 3Build control strategies that hold nitrosamines under the acceptable intake

    • How to find the acceptable intake for a new nitrosamine under International Council for Harmonisation M7.
    • Which process change, such as a new solvent or a different quench, cuts the risk at the source.
    • What a control strategy justification needs so the reviewer has no reason to ask a second question.
  4. 4Validate detection methods that prove nitrosamine levels at the limit

    • When gas chromatography with mass spectrometry fits your product and when liquid chromatography does.
    • The validation checks that a trace-level nitrosamine method must pass under guideline Q2(R2).
    • Why a method that works in the standard can fail in your tablet matrix, and how to catch it early.
  5. 5Report nitrosamine findings to European authorities without a delay

    • What to do when a result lands above the acceptable intake, as EU GMP Chapter 8 expects.
    • How to build the variation so the marketing authorisation change clears review without extra questions.
    • The common gaps in a notification that make a competent authority write back with questions.
  6. 6Answer inspectors on the spot and clear the nitrosamine questions

    • The questions inspectors ask first about your assessment, and the page in the file that answers each.
    • How to lay out the file so anyone on shift can hand over the supplier statement at once.
    • What to say when you do not yet have the answer, so the inspector writes down a plan and not a finding.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

6 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h in the briefing length and 5 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for QC, RA, API staff. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 54 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team